Neumora Therapeutics, Inc. Common Stock (NMRA) is a publicly traded Healthcare sector company. As of October 29, 2026, NMRA trades at $0.38 with a market cap of $69.16M and a P/E ratio of -0.34. NMRA moved -3.59% today. Year to date, NMRA is -76.32%; over the trailing twelve months it is -84.82%. Its 52-week range spans $0.32 to $3.65. Analyst consensus is strong buy with an average price target of $5.25. Rallies surfaces NMRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NMRA news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $0.38 |
| Market Cap | $69.16M |
| P/E Ratio | -0.34 |
| EPS | $-1.45 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.65 |
| 52-Week Low | $0.32 |
| Volume | 1.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-236.93M |
| Gross Margin | 0.00% |
5 analysts cover NMRA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.25.